Summary
In patients with colorectal liver metastases surgical resection is the only potentially curative therapy option, with reported 5-year-survival of up to 50%. Approximately 25% of all patients with colorectal cancer have synchronous liver metastases, which has been associated with extremely poor prognosis. Advances in hepatic surgery and improved response rates to modern chemotherapeutic and targeted agents have changed our approach to stage IV patients from palliative therapy towards an aggressive multidisciplinary strategy in curative intention. However, the optimal treatment sequence in these patients has not been clearly defined. This short review summarizes the advantages and disadvantages of three different treatment approaches in patients with newly diagnosed colorectal cancer and resectable synchronous liver metastases.
Similar content being viewed by others
References
Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008. CA Cancer J Clin, 58: 71–96, 2008
Nordlinger B, Guiguet M, Vaillant JC, et al. Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Association Francaise de Chirurgie. Cancer, 77: 1254–1262, 1996
Fong Y, Fortner J, Sun RL, et al. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: Analysis of 1001 consecutive cases. Ann Surg, 230: 309–318, 1999
Zitt M, Mühlmann G, Weiss H, et al. Assessment of risk-independent follow-up to detect asymptomatic recurrence after curative resection of colorectal cancer. Langenbecks Arch Surg, 391: 369–375, 2006
Choti MA, Sitzmann JV, Tiburi MF, et al. Trends in long-term survival following liver resection for hepatic colorectal metastases. Ann Surg, 235: 759–766, 2002
Abdalla EK, Vauthey JN, Ellis LM, et al. Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg, 239: 818–825, 2004
Abdalla EK, Adam R, Bilchik AJ, et al. Imroving resectability of hepatic colorectal metastases: expert consensus statement. Ann Surg Oncol, 13: 1271–1280, 2006
Tomlinson JS, Jarnagin WR, DeMatteo RP, et al. Actual 10-year survival after resection of colorectal liver metastases defines cure. J Clin Oncol, 25: 4575–4580, 2007
Bolton JS, Fuhrmann GM. Survival after resection of multiple bilobar hepatic metastases from colorectal carcinoma. Ann Surg, 231: 743–751, 2000
Chen J, Li Q, Wang C, et al. Simultaneous vs. staged resection for synchronous colorectal liver metastases: a metaanalysis. Int J Colorectal Dis, published online 29 July 2010
de Haas RJ, Adam R, Wicherts DA, et al. Comparison of simultaneous or delayed liver surgery for limited synchronous colorectal metastases. Br J Surg, 97: 1279–1289, 2010
Vauthey JN, Pawlik TM, Ribero D, et al. Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. J Clin Oncol, 24: 2065–2072, 2006
Yan TD, Chu F, Black D, et al. Synchronous resection of colorectal primary cancer and liver metastases. World J Surg, 31: 1496–1501, 2007
Chua HK, Sondenaa K, Tsiotos GG, et al. Concurrent vs. staged colectomy and hepatectomy for primary colorectal cancer with synchronous hepatic metastases. Dis Colon Rectum, 47: 1310–1316, 2004
Lambert LA, Colacchio TA, Barth RJ Jr. Interval hepatic resection of colorectal metastases improves patient selection. Arch Surg, 135: 473–479, 2000
Nordlinger B, Sorbye H, Glimelius B, et al. Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomized controlled trial. Lancet, 371: 1007–1016, 2008
Belghiti J, Hiramatsu K, Benoist S, et al. Seven hundred forty-seven hepatectomies in the late 1990s: an update to evaluate the actual risk of liver resection. J Am Coll Surg, 191: 38–46, 2000
Poon RT, Fan ST, Lo CM, et al. Improving perioperative outcome expands the role of hepatectomy in management of benign and malignant hepatobiliary disease. Analysis of 1222 consecutive patients from a consecutive database. Ann Surg, 240: 698–710, 2004
Elias D, Detroz B, Lasser P, et al. Is simultaneous hepatectomy and intestinal anastomosis safe? Am J Surg, 169: 254–260, 1995
Martin R, Paty P, Fong Y, et al. Simultaneous liver and colorectal resections are safe for synchronous colorectal liver metastasis. J Am Coll Surg, 197: 233–241, 2003
Weber JC, Bachellier P, Oussoultzoglou E, et al. Simultaneous resection of colorectal primary tumour and synchronous liver metastases. Br J Surg, 90: 956–962, 2003
Capusotti L, Ferrero A, Vigano L, et al. Major liver resections synchronous with colorectal surgery. Ann Surg Oncol, 14: 196–202, 2007
Tanaka K, Shimada H, Matsuo K, et al. Outcome after simultaneous colorectal and hepatic resection for colorectal cancer with synchronous metastases. Surgery, 136: 650–659, 2004
Thelen A, Jonas S, Benckert C, et al. Simultaneous versus staged liver resection of synchronous liver metastases from colorectal cancer. Int J Colorectal Dis, 22: 1269–1276, 2007
Reddy SK, Pawlik TM, Zorzi D, et al. Simultaneous resection of colorectal cancer and synchronous liver metastases: a multi-institutional analysis. Ann Surg Oncol, 14: 3481–3491, 2007
Mentha G, Majno PE, Andres A, et al. Neoadjuvant chemotherapy and resection of advanced liver metastases before treatment of the colorectal primary. Br J Surg, 93: 872–878, 2006
Verhoef C, van der Pool AEM, Nuyttens JJ, et al. The "Liver-First approach" for patients with locally advanced rectal cancer and synchronous liver metastases. Dis Colon Rectum, 52: 23–30, 2009
Brouquet A, Mortenson MM, Vauthey JN, Surgical strategies for synchronous colorectal liver metastases in 156 consecutive patients: classic, combined or reverse strategy? J Am Coll Surg, 210: 934–941, 2010
Wichmann MW, Hüttl TP, Winter H, et al. Immunological effects of laparoscopic versus open colorectal surgery. Arch Surg, 140: 692–697, 2005
Poultsides GA, Servais EL, Saltz LB, et al. Outcome of primary tumor in patients with synchronous stage IV colorectal cancer receiving combination chemotherapy without surgery as initial treatment. J Clin Oncol, 27: 3379–3384, 2009
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Zitt, M. Bowel First? Simultaneous Resection? Liver First? Treatment options in patients with colorectal cancer and resectable synchronous liver metastases. memo 4, 79–81 (2011). https://doi.org/10.1007/s12254-011-0261-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12254-011-0261-8